We are the voice of the innovative pharmaceutical and biopharmaceutical industry, working with Government, regulators and other stakeholders to promote a receptive environment for a strong and progressive industry in the UK, capable of providing the best medicines for patients.
Our strategy and operating plans are actively developed in line with our Imperatives, based on input from the imperative leads and other, broader strategy studies as needed. For further information visit: